{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T12:36:46Z","timestamp":1793450206377,"version":"4.5.0"},"reference-count":38,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"13","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,3]]},"DOI":"10.1097\/md.0000000000006495","type":"journal-article","created":{"date-parts":[[2017,3,28]],"date-time":"2017-03-28T16:58:06Z","timestamp":1490720286000},"page":"e6495","source":"Crossref","is-referenced-by-count":27,"title":["Ovarian response prediction in controlled ovarian stimulation for IVF using anti-M\u00fcllerian hormone in Chinese women"],"prefix":"10.1097","volume":"96","author":[{"given":"Haiyan","family":"Zheng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiping","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongzi","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiawei","family":"Ling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yixuan","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haiying","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianqiao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-43-20210309","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1196\/annals.1434.011","article-title":"Ovarian reserve","volume":"1127","author":"Coccia","year":"2008","journal-title":"Ann N Y Acad Sci"},{"key":"R2-43-20210309","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.ejogrb.2009.05.008","article-title":"Ovarian reserve screening in infertility: practical applications and theoretical directions for research","volume":"146","author":"Sills","year":"2009","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"R3-43-20210309","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/1477-7827-9-23","article-title":"Defining ovarian reserve to better understand ovarian aging","volume":"9","author":"Gleicher","year":"2011","journal-title":"Reprod Biol Endocrinol"},{"key":"R4-43-20210309","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1097\/00001703-200406000-00005","article-title":"Assessment of ovarian reserve","volume":"16","author":"Bukulmez","year":"2004","journal-title":"Curr Opin Obstet Gynecol"},{"key":"R5-43-20210309","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1093\/humrep\/deq339","article-title":"Multi-marker assessment of ovarian reserve predicts oocyte yield after ovulation induction","volume":"26","author":"Al-Azemi","year":"2011","journal-title":"Hum Reprod"},{"key":"R6-43-20210309","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/j.fertnstert.2013.04.024","article-title":"Prediction of an excessive response in in vitro fertilization from patient characteristics and ovarian reserve tests and comparison in subgroups: an individual patient data meta-analysis","volume":"100","author":"Broer","year":"2013","journal-title":"Fertil Steril"},{"key":"R7-43-20210309","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1093\/humupd\/dms041","article-title":"Added value of ovarian reserve testing on patient characteristics in the prediction of ovarian response and ongoing pregnancy: an individual patient data approach","volume":"19","author":"Broer","year":"2013","journal-title":"Hum Reprod Update"},{"key":"R8-43-20210309","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1093\/humrep\/deu266","article-title":"Ovarian response prediction in GnRH antagonist treatment for IVF using anti-Mullerian hormone","volume":"30","author":"Hamdine","year":"2015","journal-title":"Hum Reprod"},{"key":"R9-43-20210309","doi-asserted-by":"crossref","first-page":"3413","DOI":"10.1093\/humrep\/der318","article-title":"Predictive factors of ovarian response and clinical outcome after IVF\/ICSI following a rFSH\/GnRH antagonist protocol with or without oral contraceptive pre-treatment","volume":"26","author":"Andersen","year":"2011","journal-title":"Hum Reprod"},{"key":"R10-43-20210309","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1093\/humrep\/den480","article-title":"Anti-Mullerian hormone-based approach to controlled ovarian stimulation for assisted conception","volume":"24","author":"Nelson","year":"2009","journal-title":"Hum Reprod"},{"key":"R11-43-20210309","doi-asserted-by":"crossref","first-page":"2353","DOI":"10.1093\/humrep\/der182","article-title":"Anti-Mullerian hormone-tailored stimulation protocols improve outcomes whilst reducing adverse effects and costs of IVF","volume":"26","author":"Yates","year":"2011","journal-title":"Hum Reprod"},{"key":"R12-43-20210309","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/1472-6874-12-29","article-title":"The OPTIMIST study: optimisation of cost effectiveness through individualised FSH stimulation dosages for IVF treatment. A randomised controlled trial","volume":"12","author":"van Tilborg","year":"2012","journal-title":"BMC Womens Health"},{"key":"R13-43-20210309","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1016\/j.fertnstert.2007.05.040","article-title":"Anti-Mullerian hormone: correlation of early follicular, ovulatory and midluteal levels with ovarian response and cycle outcome in intracytoplasmic sperm injection patients","volume":"89","author":"Elgindy","year":"2008","journal-title":"Fertil Steril"},{"key":"R14-43-20210309","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/j.fertnstert.2008.10.042","article-title":"A prospective, comparative analysis of anti-Mullerian hormone, inhibin-B, and three-dimensional ultrasound determinants of ovarian reserve in the prediction of poor response to controlled ovarian stimulation","volume":"93","author":"Jayaprakasan","year":"2010","journal-title":"Fertil Steril"},{"key":"R15-43-20210309","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1016\/S1472-6483(10)61053-X","article-title":"Anti-Mullerian hormone as a predictor of IVF outcome","volume":"14","author":"Lekamge","year":"2007","journal-title":"Reprod Biomed Online"},{"key":"R16-43-20210309","doi-asserted-by":"crossref","first-page":"3065","DOI":"10.1093\/humrep\/17.12.3065","article-title":"Serum anti-Mullerian hormone levels: a novel measure of ovarian reserve","volume":"17","author":"van Rooij","year":"2002","journal-title":"Hum Reprod"},{"key":"R17-43-20210309","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1016\/j.fertnstert.2012.12.048","article-title":"Antimullerian hormone in gonadotropin releasing-hormone antagonist cycles: prediction of ovarian response and cumulative treatment outcome in good-prognosis patients","volume":"99","author":"Arce","year":"2013","journal-title":"Fertil Steril"},{"key":"R18-43-20210309","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/S0015-0282(01)03201-0","article-title":"Early follicular serum mullerian-inhibiting substance levels are associated with ovarian response during assisted reproductive technology cycles","volume":"77","author":"Seifer","year":"2002","journal-title":"Fertil Steril"},{"key":"R19-43-20210309","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1093\/humrep\/der092","article-title":"ESHRE consensus on the definition of \u2019poor response\u2019 to ovarian stimulation for in vitro fertilization: the Bologna criteria","volume":"26","author":"Ferraretti","year":"2011","journal-title":"Hum Reprod"},{"key":"R20-43-20210309","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1093\/humupd\/dmt037","article-title":"Individualization of controlled ovarian stimulation in IVF using ovarian reserve markers: from theory to practice","volume":"20","author":"La Marca","year":"2014","journal-title":"Hum Reprod Update"},{"key":"R21-43-20210309","doi-asserted-by":"crossref","first-page":"2414","DOI":"10.1093\/humrep\/dem204","article-title":"Serum anti-Mullerian hormone and FSH: prediction of live birth and extremes of response in stimulated cycles\u2014implications for individualization of therapy","volume":"22","author":"Nelson","year":"2007","journal-title":"Hum Reprod"},{"key":"R22-43-20210309","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1093\/humupd\/dmp036","article-title":"Anti-Mullerian hormone (AMH) as a predictive marker in assisted reproductive technology (ART)","volume":"16","author":"La Marca","year":"2010","journal-title":"Hum Reprod Update"},{"key":"R23-43-20210309","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1093\/humupd\/dmq034","article-title":"AMH and AFC as predictors of excessive response in controlled ovarian hyperstimulation: a meta-analysis","volume":"17","author":"Broer","year":"2011","journal-title":"Hum Reprod Update"},{"key":"R24-43-20210309","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.1093\/humrep\/deg451","article-title":"Intravenous albumin does not prevent moderate-severe ovarian hyperstimulation syndrome in high-risk IVF patients: a randomized controlled study","volume":"18","author":"Bellver","year":"2003","journal-title":"Hum Reprod"},{"key":"R25-43-20210309","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1016\/j.fertnstert.2008.08.127","article-title":"Circulating basal anti-Mullerian hormone levels as predictor of ovarian response in women undergoing ovarian stimulation for in vitro fertilization","volume":"92","author":"Nardo","year":"2009","journal-title":"Fertil Steril"},{"key":"R26-43-20210309","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1111\/j.1471-0528.2012.03412.x","article-title":"Development of a nomogram based on markers of ovarian reserve for the individualisation of the follicle-stimulating hormone starting dose in in vitro fertilisation cycles","volume":"119","author":"La Marca","year":"2012","journal-title":"BJOG"},{"key":"R27-43-20210309","doi-asserted-by":"crossref","first-page":"2022","DOI":"10.1093\/humrep\/del127","article-title":"Basal level of anti-Mullerian hormone is associated with oocyte quality in stimulated cycles","volume":"21","author":"Ebner","year":"2006","journal-title":"Hum Reprod"},{"key":"R28-43-20210309","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.fertnstert.2006.06.019","article-title":"Antimullerian hormone predicts ovarian responsiveness, but not embryo quality or pregnancy, after in vitro fertilization or intracyoplasmic sperm injection","volume":"87","author":"Smeenk","year":"2007","journal-title":"Fertil Steril"},{"key":"R29-43-20210309","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/1757-2215-6-3","article-title":"External validation of anti-Mullerian hormone based prediction of live birth in assisted conception","volume":"6","author":"Khader","year":"2013","journal-title":"J Ovarian Res"},{"key":"R30-43-20210309","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1016\/S1472-6483(10)60480-4","article-title":"Anti-Mullerian hormone: a marker for oocyte quantity, oocyte quality and embryo quality?","volume":"16","author":"Lie","year":"2008","journal-title":"Reprod Biomed Online"},{"key":"R31-43-20210309","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.fertnstert.2014.09.041","article-title":"Antimullerian hormone as predictor of implantation and clinical pregnancy after assisted conception: a systematic review and meta-analysis","volume":"103","author":"Tal","year":"2015","journal-title":"Fertil Steril"},{"key":"R32-43-20210309","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1093\/humrep\/des101","article-title":"The value of anti-Mullerian hormone measurement in the long GnRH agonist protocol: association with ovarian response and gonadotrophin-dose adjustments","volume":"27","author":"Anckaert","year":"2012","journal-title":"Hum Reprod"},{"key":"R33-43-20210309","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1093\/humupd\/dmu003","article-title":"The predictive accuracy of anti-Mullerian hormone for live birth after assisted conception: a systematic review and meta-analysis of the literature","volume":"20","author":"Iliodromiti","year":"2014","journal-title":"Hum Reprod Update"},{"key":"R34-43-20210309","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/S0015-0282(97)00557-8","article-title":"Use of the antral follicle count to predict the outcome of assisted reproductive technologies","volume":"69","author":"Chang","year":"1998","journal-title":"Fertil Steril"},{"key":"R35-43-20210309","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.fertnstert.2007.11.042","article-title":"Antral follicle count (AFC) can be used in the prediction of ovarian response but cannot predict the oocyte\/embryo quality or the in vitro fertilization outcome in an egg donation program","volume":"91","author":"Melo","year":"2009","journal-title":"Fertil Steril"},{"key":"R36-43-20210309","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1016\/j.fertnstert.2009.04.040","article-title":"The antral follicle count: practical recommendations for better standardization","volume":"94","author":"Broekmans","year":"2010","journal-title":"Fertil Steril"},{"key":"R37-43-20210309","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1016\/j.fertnstert.2013.12.039","article-title":"Value of antimullerian hormone as a prognostic indicator of in vitro fertilization outcome","volume":"101","author":"Reichman","year":"2014","journal-title":"Fertil Steril"},{"key":"R38-43-20210309","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1093\/humrep\/der134","article-title":"Live birth chances in women with extremely low-serum anti-Mullerian hormone levels","volume":"26","author":"Weghofer","year":"2011","journal-title":"Hum Reprod"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000006495","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T02:46:40Z","timestamp":1620960400000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00005792-201703310-00043"}},"subtitle":["A retrospective cohort study"],"short-title":[],"issued":{"date-parts":[[2017,3]]},"references-count":38,"journal-issue":{"issue":"13","published-print":{"date-parts":[[2017]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000006495","relation":{},"ISSN":["0025-7974"],"issn-type":[{"value":"0025-7974","type":"print"}],"subject":[],"published":{"date-parts":[[2017,3]]}}}